Verrica Pharmaceuticals Inc. - Common Stock (NQ:VRCA)

4.380 -0.135 (-2.99%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verrica Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023 ↗

February 13, 2023

Via Benzinga

Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

January 24, 2023

From Verrica Pharmaceuticals Inc.

Via GlobeNewswire

Verrica Pharmaceuticals Announces the Successful Technology Transfer of Bulk Solution Manufacturing of VP-102 to Piramal Pharma Solutions

January 04, 2023

From Verrica Pharmaceuticals Inc.

Via GlobeNewswire

Verrica Pharmaceuticals's Return On Capital Employed Overview ↗

December 02, 2022

Via Benzinga

Analysts Still Believe Verrica's Ycanth Is Approvable Despite FDA Response Letter ↗

June 29, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 02, 2022

Via Benzinga

Verrica Pharmaceuticals Reports Third Quarter 2022 Financial Results

November 07, 2022

From Verrica Pharmaceuticals Inc.

Via GlobeNewswire

NASDAQ:VRCA Long Term Investor Alert: Investigation over Possible Wrongdoing at Verrica Pharmaceuticals Inc. ↗

October 05, 2022

San Diego, CA -- (SBWIRE) -- 10/05/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Verrica Pharmaceuticals Inc.

Via SBWire

Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Reminds Verrica Pharmaceuticals Inc. (VRCA) Investors of Class Action and Last Few Hours to Actively Participate

August 05, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

August 04, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

August 04, 2022

From The Schall Law Firm

Via Business Wire

VERRICA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

August 03, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

August 03, 2022

From The Schall Law Firm

Via Business Wire

VRCA DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Verrica Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCA

July 31, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

$10 Million Bet On This Stock? 3 Penny Stocks Insiders are Buying ↗

July 06, 2022

U.S. stock futures traded slightly lower this morning on Wednesday after the Nasdaq recorded sharp gains on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Wells Fargo & Company Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - WFC

July 01, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Boeing, PriceSmart And 80 Biggest Movers From Yesterday ↗

July 13, 2022

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

Via Benzinga

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday ↗

July 08, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Via Benzinga

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial ↗

June 30, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session ↗

July 07, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.

Via Benzinga

Verrica Holds Type A Meeting With FDA For Potential Approval Of Skin Infection Candidate ↗

June 28, 2022

The U.S. Food and Drug Administration (FDA) convened a Type A meeting with Verrica Pharmaceuticals (NASDAQ: VRCA) regarding the course of action for the clearance of its drug candidate VP-102.

Via Benzinga

Verrica Pharmaceuticals Inc. Investor News: Robbins LLP is Investigating Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Shareholders

June 22, 2022

From Robbins LLP

Via Business Wire

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

NASDAQ:VRCA Investor Notice: Lawsuit Alleges Misleading Statements by Verrica Pharmaceuticals Inc. ↗

June 21, 2022

San Diego, CA -- (SBWIRE) -- 06/21/2022 -- An investor, who purchased NASDAQ:VRCA shares, filed a lawsuit against Verrica Pharmaceuticals Inc over alleged violations of Federal Securities Laws.

Via SBWire

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session ↗

June 30, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...

Via Benzinga

NATIONALLY RANKED ROSEN LAW FIRM Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - VRCA

June 20, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Verrica Pharmaceuticals, Inc. (VRCA) Investors and Encourages Investors to Contact the Firm Before August 5, 2022

June 17, 2022

From Kirby McInerney LLP

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 14, 2022

Gainers

Via Benzinga

VRCA Investor Update: Robbins LLP Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. (VRCA)

June 13, 2022

From Robbins LLP

Via Business Wire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

June 13, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.